• Latest Posts

ReNeuron backed by First-Class Investor Woodford to advance Stem Cell Therapy

Novartis declines Gamida’s buyout deal for the second time

Interview with CELLPROTHERA, the regenerative medicine pioneer

Important Bilateral Academic Agreement for the Future of iPS Cell Therapy

Stem Cell Therapy for Degenerative Muscle Disease thanks to ENDOSTEM Project

Belgian Promethera received approval to start World first Phase IIb/III stem-cell based urea cycle disorders treatment

ADVERTISEMENT

The new strategy of Novartis to acquire Gamida Cell

Stemedica International succeed in a pre-clinical trial to treat Alzheimer’s disease with stem cells

ADVERTISEMENT